SRTS vs. SMLR, NNOX, STIM, SMTI, ZIMV, RCEL, SNWV, NVRO, NYXH, and ELMD
Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Semler Scientific (SMLR), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), AVITA Medical (RCEL), SANUWAVE Health (SNWV), Nevro (NVRO), Nyxoah (NYXH), and Electromed (ELMD). These companies are all part of the "medical equipment" industry.
Sensus Healthcare vs.
Semler Scientific (NASDAQ:SMLR) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings, risk and community ranking.
Semler Scientific presently has a consensus target price of $71.00, suggesting a potential upside of 113.02%. Sensus Healthcare has a consensus target price of $13.00, suggesting a potential upside of 200.23%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Sensus Healthcare is more favorable than Semler Scientific.
Sensus Healthcare received 184 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 68.89% of users gave Sensus Healthcare an outperform vote while only 66.67% of users gave Semler Scientific an outperform vote.
In the previous week, Semler Scientific had 6 more articles in the media than Sensus Healthcare. MarketBeat recorded 8 mentions for Semler Scientific and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.14 beat Semler Scientific's score of 0.63 indicating that Sensus Healthcare is being referred to more favorably in the news media.
Semler Scientific has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.
Semler Scientific has a net margin of 72.65% compared to Sensus Healthcare's net margin of 15.90%. Semler Scientific's return on equity of 50.77% beat Sensus Healthcare's return on equity.
Semler Scientific has higher revenue and earnings than Sensus Healthcare. Semler Scientific is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by company insiders. Comparatively, 9.4% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
Semler Scientific beats Sensus Healthcare on 11 of the 19 factors compared between the two stocks.
Get Sensus Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sensus Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:SRTS) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy SRTS Stock Free SRTS Stock Alerts